Richard L Kimbrough
University of Texas Health Science Center at San Antonio
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Richard L Kimbrough.
American Journal of Ophthalmology | 1978
Howard M. Leibowitz; Allan Kupferman; Robert H Stewart; Richard L Kimbrough
Penetration of an ophthalmic suspension of 0.1% dexamethasone acetate into the rabbit cornea and aqueous humor was unaffected by the status of the corneal epithelium or by the presence or absence of intraocular inflammation. However, the total quantity of this corticosteroid that could be measured in the cornea or aqueous humor was significantly less than that produced by either dexamethason alcohol or dexamethasone sodium phosphate. Despite this, dexamethasone acetate was the most effective of the three dexamethasone derivatives in suppressing inflammation in the cornea, which indicates that following topical administration to the eye it is the most potent of the dexamethasone derivatives studied. This greater therapeutic effect does not seem to be accompanied by a greater propensity to increase intraocular pressure. Comparison of the intraocular pressureincreasing effect in known corticosteroid responders of dexamethasone acetate with that of dexamethasone sodium phosphate, the least effective of the dexamethasone products studied, demonstrated no difference between the two drugs. These data support the conclusion that dexamethasone acetate is superior to the commercially available dexamethasone derivatives for use as a topical ocular anti-inflammatory agent.
Ophthalmic surgery | 1985
Dan A Willis; Robert H Stewart; Richard L Kimbrough
Two patients developed pupillary block glaucoma after extracapsular cataract extraction with implantation of a posterior chamber lens but without peripheral iridectomies. The intraocular pressure of each eye was successfully controlled with laser iridotomy. No long-term medication was necessary to control their intraocular pressures.
Journal of Glaucoma | 1995
Lindsay Arnoult; Zebulon L. Bowman; Richard L Kimbrough; Robert H Stewart
PurposeWe report two cases of periocular cutaneous hypopigmentation and one case of hyperpigmentation which appeared while the patients were on betaxolol. We propose several possible explanations for this phenomenon. MethodsCharts of three patients with glaucoma who developed periocular cutaneous pigmentary changes while on betaxolol were reviewed retrospectively. ResultsCase #1 was a 47-year-old black man with primary open angle glaucoma, started on betaxolol 0.5% in both eyes in January 1981. Bilateral hypopigmentation of the eyelids was first documented in October 1987. Betaxolol was discontinued in November 1987. In December 1990 the pigmentation had returned to normal. Case #2 was a 4-month-old white boy with unilateral primary infantile glaucoma who was started in September 1992 on betaxolol 0.25% in the left eye. Left lower eyelid hypopigmentation was seen in April 1993. Betaxolol was discontinued in July 1993. Since that time the pigmentation has returned to normal. Case #3 was a 75-year-old black man with primary open angle glaucoma. He was placed on betaxolol 0.5% in both eyes in 1987 and in March 1988 hyperpigmentation of the eyelids was seen bilaterally. Betaxolol was discontinued, and by December 1990 the pigmentation had returned to normal. ConclusionThese three case histories suggest that the periocular cutaneous changes described herein are secondary to local instillation of betaxolol.
Ophthalmic surgery | 1986
Robert H Stewart; Richard L Kimbrough; Phyllis C Okereke
We present the early results in a small series of 12 eyes of 12 patients with uncontrolled glaucoma who underwent trabeculectomy with implantation of a Mendez Glaucoma Seton. All eyes, except one with neovascular glaucoma, had had multiple glaucoma surgery and all, without exception, were on maximal tolerated medical therapy prior to surgery. The follow-up period ranged from one and one fourth to three and three fourths months. The surgical technique was the same in all cases. Our success rate was 33.3% or 40%, if one eye with persistent hypotonia could be counted as a success. This result is inferior to those quoted in the literature with the use of other types of setons, and especially to the results of Dr. Antonio Mendez who used a similar implant.
Ophthalmic surgery | 1987
Richard L Kimbrough; Robert H Stewart; P C Okereke
We developed a prospective clinical study to determine the effectiveness of a new method of retrobulbar anesthesia and akinesia of the levator and orbicularis muscles. This study involved 50 patients who underwent extracapsular cataract extractions (ECCE) with intraocular lens implant (IOL). We found levator and orbicularis muscle akinesia was achieved in 49 of 50 eyes. One reblock was necessary. We also wish to point out the advantages of this technique as a means of reducing the rare but serious complications associated with retrobulbar anesthesia.
Ophthalmic surgery | 1988
Robert H Stewart; Richard L Kimbrough; Paul F Engstrom; Bruce D Cameron
Intravenous lidocaine suppresses the cough reflex in patients undergoing local operative procedures. Many anti-tussive agents suppress the cough reflex by suppressing the respiratory center. Intravenous lidocaine produces no respiratory depression in doses that suppress the cough reflex. Intravenous lidocaine should be available during all intraocular surgical procedures so it can be used when indicated.
Archives of Ophthalmology | 1986
Robert H Stewart; Richard L Kimbrough; Richard L. Ward
Archives of Ophthalmology | 1979
Robert H Stewart; Richard L Kimbrough
Ophthalmic surgery | 1982
Richard L Kimbrough; Robert H Stewart; William L Decker; Thomas C Praeger
Ophthalmic surgery | 1990
Florence Davidovski; Robert H Stewart; Richard L Kimbrough
Collaboration
Dive into the Richard L Kimbrough's collaboration.
University of Texas Health Science Center at San Antonio
View shared research outputs